image
Technology - Hardware, Equipment & Parts - NASDAQ - US
$ 1.07
5.94 %
$ 37.1 M
Market Cap
-35.67
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one LUNA stock under the worst case scenario is HIDDEN Compared to the current market price of 1.07 USD, Luna Innovations Incorporated is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one LUNA stock under the base case scenario is HIDDEN Compared to the current market price of 1.07 USD, Luna Innovations Incorporated is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one LUNA stock under the best case scenario is HIDDEN Compared to the current market price of 1.07 USD, Luna Innovations Incorporated is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
109 M REVENUE
25.12%
-1.88 M OPERATING INCOME
27.26%
-570 K NET INCOME
-41.24%
-8.57 M OPERATING CASH FLOW
-191.10%
-11.1 M INVESTING CASH FLOW
-525.28%
9.51 M FINANCING CASH FLOW
852.53%
30.7 M REVENUE
5.28%
1.15 M OPERATING INCOME
638.32%
461 K NET INCOME
128.88%
2.33 M OPERATING CASH FLOW
139.05%
-602 K INVESTING CASH FLOW
17.87%
1.09 M FINANCING CASH FLOW
-82.97%
Balance Sheet Luna Innovations Incorporated
image
Current Assets 87.9 M
Cash & Short-Term Investments 6.02 M
Receivables 40.9 M
Other Current Assets 40.9 M
Non-Current Assets 63.1 M
Long-Term Investments 0
PP&E 9.55 M
Other Non-Current Assets 53.6 M
Current Liabilities 33.6 M
Accounts Payable 8.11 M
Short-Term Debt 4.79 M
Other Current Liabilities 20.7 M
Non-Current Liabilities 24 M
Long-Term Debt 23.5 M
Other Non-Current Liabilities 444 K
EFFICIENCY
Earnings Waterfall Luna Innovations Incorporated
image
Revenue 109 M
Cost Of Revenue 43 M
Gross Profit 66.5 M
Operating Expenses 68.4 M
Operating Income -1.88 M
Other Expenses -1.31 M
Net Income -570 K
RATIOS
60.73% GROSS MARGIN
60.73%
-1.72% OPERATING MARGIN
-1.72%
8.47% NET MARGIN
8.47%
9.93% ROE
9.93%
6.14% ROA
6.14%
-1.47% ROIC
-1.47%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Luna Innovations Incorporated
image
Net Income -570 K
Depreciation & Amortization 5.43 M
Capital Expenditures -2.94 M
Stock-Based Compensation 4.23 M
Change in Working Capital -15.4 M
Others -2.24 M
Free Cash Flow -11.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Luna Innovations Incorporated
image
LUNA has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Luna Innovations Incorporated
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 years ago
Sep 04, 2019
Sell 453 K USD
Carilion Clinic
10 percent owner
- 71701
6.32 USD
5 years ago
Sep 05, 2019
Sell 328 K USD
Carilion Clinic
10 percent owner
- 48953
6.71 USD
5 years ago
Sep 06, 2019
Sell 342 K USD
Carilion Clinic
10 percent owner
- 51047
6.7 USD
5 years ago
Aug 30, 2019
Sell 338 K USD
Carilion Clinic
10 percent owner
- 53265
6.35 USD
5 years ago
Sep 03, 2019
Sell 534 K USD
Carilion Clinic
10 percent owner
- 83634
6.39 USD
5 years ago
Aug 28, 2019
Sell 691 K USD
Carilion Clinic
10 percent owner
- 109604
6.3 USD
5 years ago
Aug 29, 2019
Sell 508 K USD
Carilion Clinic
10 percent owner
- 81796
6.21 USD
5 years ago
Aug 26, 2019
Sell 326 K USD
Carilion Clinic
10 percent owner
- 52220
6.25 USD
5 years ago
Aug 27, 2019
Sell 297 K USD
Carilion Clinic
10 percent owner
- 47780
6.22 USD
5 years ago
Aug 21, 2019
Sell 313 K USD
Carilion Clinic
Director
- 51699
6.06 USD
5 years ago
Aug 21, 2019
Sell 313 K USD
Carilion Clinic
10 percent owner
- 51699
6.06 USD
5 years ago
Aug 22, 2019
Sell 293 K USD
Carilion Clinic
Director
- 48301
6.07 USD
5 years ago
Aug 22, 2019
Sell 293 K USD
Carilion Clinic
10 percent owner
- 48301
6.07 USD
5 years ago
Aug 19, 2019
Sell 179 K USD
Carilion Clinic
10 percent owner
- 29768
6.02 USD
5 years ago
Aug 19, 2019
Sell 179 K USD
Carilion Clinic
Director
- 29768
6.02 USD
5 years ago
Aug 20, 2019
Sell 415 K USD
Carilion Clinic
Director
- 68732
6.04 USD
5 years ago
Aug 20, 2019
Sell 415 K USD
Carilion Clinic
10 percent owner
- 68732
6.04 USD
5 years ago
Aug 21, 2019
Sell 9.02 K USD
Carilion Clinic
Director
- 1500
6.01 USD
5 years ago
Aug 21, 2019
Sell 9.02 K USD
Carilion Clinic
10 percent owner
- 1500
6.01 USD
5 years ago
Aug 14, 2019
Sell 131 K USD
Carilion Clinic
10 percent owner
- 23336
5.62 USD
5 years ago
Aug 15, 2019
Sell 312 K USD
Carilion Clinic
10 percent owner
- 55969
5.57 USD
5 years ago
Aug 12, 2019
Sell 470 K USD
Carilion Clinic
10 percent owner
- 83861
5.61 USD
5 years ago
Aug 13, 2019
Sell 210 K USD
Carilion Clinic
10 percent owner
- 36834
5.7 USD
5 years ago
Aug 08, 2019
Sell 286 K USD
Carilion Clinic
10 percent owner
- 54495
5.25 USD
5 years ago
Jul 31, 2019
Sell 226 K USD
Carilion Clinic
10 percent owner
- 42200
5.35 USD
5 years ago
Aug 01, 2019
Sell 17.4 K USD
Carilion Clinic
10 percent owner
- 3305
5.25 USD
5 years ago
Jul 26, 2019
Sell 35.8 K USD
Carilion Clinic
10 percent owner
- 7154
5 USD
5 years ago
Jul 29, 2019
Sell 86.2 K USD
Carilion Clinic
10 percent owner
- 17178
5.02 USD
5 years ago
Jul 24, 2019
Sell 67.3 K USD
Carilion Clinic
Director
- 13466
5 USD
5 years ago
Jul 24, 2019
Sell 67.3 K USD
Carilion Clinic
10 percent owner
- 13466
5 USD
5 years ago
Jul 25, 2019
Sell 5.56 K USD
Carilion Clinic
10 percent owner
- 1113
5 USD
5 years ago
Jul 25, 2019
Sell 5.56 K USD
Carilion Clinic
Director
- 1113
5 USD
5 years ago
Jul 22, 2019
Sell 442 K USD
Carilion Clinic
10 percent owner
- 87960
5.02 USD
5 years ago
Jul 23, 2019
Sell 28 K USD
Carilion Clinic
10 percent owner
- 5590
5.01 USD
5 years ago
Jul 18, 2019
Sell 86 K USD
Carilion Clinic
10 percent owner
- 17196
5 USD
5 years ago
Jul 19, 2019
Sell 151 K USD
Carilion Clinic
10 percent owner
- 30208
5 USD
5 years ago
Jul 16, 2019
Sell 86.8 K USD
Carilion Clinic
10 percent owner
- 17300
5.02 USD
5 years ago
Jul 17, 2019
Sell 14.2 K USD
Carilion Clinic
10 percent owner
- 2835
5 USD
6 years ago
Jul 16, 2018
Sell 134 K USD
Carilion Clinic
10 percent owner
- 39497
3.4 USD
6 years ago
Jul 09, 2018
Sell 30.4 K USD
Carilion Clinic
10 percent owner
- 8955
3.4 USD
6 years ago
May 31, 2018
Sell 340 USD
Carilion Clinic
10 percent owner
- 100
3.4 USD
6 years ago
May 25, 2018
Sell 20.8 K USD
Carilion Clinic
10 percent owner
- 6100
3.41 USD
6 years ago
May 29, 2018
Sell 2.04 K USD
Carilion Clinic
10 percent owner
- 600
3.4 USD
6 years ago
May 21, 2018
Sell 3.11 K USD
Carilion Clinic
10 percent owner
- 915
3.4 USD
6 years ago
May 17, 2018
Sell 7.12 K USD
Carilion Clinic
10 percent owner
- 2095
3.4 USD
6 years ago
May 18, 2018
Sell 343 K USD
Carilion Clinic
10 percent owner
- 100835
3.4 USD
6 years ago
May 08, 2018
Sell 144 K USD
Carilion Clinic
10 percent owner
- 41854
3.44 USD
6 years ago
May 09, 2018
Sell 77.4 K USD
Carilion Clinic
10 percent owner
- 22754
3.4 USD
6 years ago
May 03, 2018
Sell 13.3 K USD
Carilion Clinic
10 percent owner
- 3900
3.4 USD
6 years ago
May 01, 2018
Sell 48.1 K USD
Carilion Clinic
10 percent owner
- 14103
3.41 USD
6 years ago
May 02, 2018
Sell 21.4 K USD
Carilion Clinic
10 percent owner
- 6275
3.41 USD
6 years ago
Apr 16, 2018
Sell 115 K USD
Carilion Clinic
10 percent owner
- 33700
3.41 USD
6 years ago
Apr 17, 2018
Sell 18.6 K USD
Carilion Clinic
10 percent owner
- 5472
3.4 USD
6 years ago
Apr 12, 2018
Sell 206 K USD
Carilion Clinic
10 percent owner
- 59980
3.43 USD
6 years ago
Apr 13, 2018
Sell 58.5 K USD
Carilion Clinic
10 percent owner
- 18065
3.24 USD
6 years ago
Apr 10, 2018
Sell 84.9 K USD
Carilion Clinic
10 percent owner
- 24666
3.44 USD
6 years ago
Apr 11, 2018
Sell 66.2 K USD
Carilion Clinic
10 percent owner
- 19346
3.42 USD
7 years ago
Aug 24, 2017
Bought 14.3 K USD
Graeff Scott A
Chief Executive Officer
+ 10000
1.43 USD
7 years ago
Aug 24, 2017
Bought 1.68 K USD
Messick Dale E
Chief Financial Officer
+ 1200
1.3999 USD
7 years ago
Aug 24, 2017
Bought 1.68 K USD
Messick Dale E
Chief Financial Officer
+ 1200
1.3999 USD
7 years ago
Aug 24, 2017
Bought 12.3 K USD
Messick Dale E
Chief Financial Officer
+ 8800
1.4 USD
7 years ago
Aug 24, 2017
Bought 12.3 K USD
Messick Dale E
Chief Financial Officer
+ 8800
1.4 USD
7 years ago
Jan 27, 2017
Sell 118 K USD
Carilion Health System
Director
- 59400
1.98 USD
7 years ago
Jan 27, 2017
Sell 118 K USD
Carilion Health System
10 percent owner
- 59400
1.98 USD
7 years ago
Jan 30, 2017
Sell 50.3 K USD
Carilion Health System
Director
- 25166
2 USD
7 years ago
Jan 30, 2017
Sell 50.3 K USD
Carilion Health System
10 percent owner
- 25166
2 USD
8 years ago
Aug 17, 2016
Bought 22.2 K USD
Wise Michael W.
Director
+ 20000
1.11 USD
8 years ago
Aug 15, 2016
Bought 46 K USD
ROEDEL RICHARD
Director
+ 38373
1.2 USD
8 years ago
Aug 12, 2016
Bought 50 K USD
ROEDEL RICHARD
Director
+ 40000
1.25 USD
8 years ago
Jun 15, 2016
Bought 29.2 K USD
ROEDEL RICHARD
Director
+ 24338
1.2 USD
8 years ago
Jun 14, 2016
Bought 17.1 K USD
ROEDEL RICHARD
Director
+ 14862
1.15 USD
8 years ago
Jun 14, 2016
Bought 8.53 K USD
Pastor Donald
Director
+ 7200
1.185 USD
8 years ago
May 16, 2016
Bought 3.18 K USD
Messick Dale E
Chief Financial Officer
+ 3000
1.06 USD
10 years ago
May 30, 2014
Sell 144 K USD
Wise Michael W.
Director
- 100050
1.4347 USD
10 years ago
May 30, 2014
Sell 144 K USD
Wise Michael W.
Director
- 100050
1.4347 USD
10 years ago
Jan 23, 2014
Sell 2 M USD
Murphy Kent A
10 percent owner
- 1072022
1.8659 USD
10 years ago
Jan 24, 2014
Sell 661 K USD
Murphy Kent A
10 percent owner
- 389641
1.6954 USD
15 years ago
Jan 13, 2010
Bought 42.3 K USD
Dalhouse Warner
Director
+ 10000
4.2334 USD
14 years ago
Aug 17, 2010
Bought 1.9 K USD
Messick Dale E
Interim President and COO
+ 1000
1.9 USD
14 years ago
Aug 16, 2010
Bought 2.85 K USD
Messick Dale E
Interim President and COO
+ 1500
1.9 USD
14 years ago
Aug 18, 2010
Bought 3.01 K USD
Graeff Scott A
Interim CFO; CCO
+ 1625
1.85 USD
14 years ago
Aug 17, 2010
Bought 2.73 K USD
Graeff Scott A
Interim CFO; CCO
+ 1475
1.85 USD
14 years ago
Aug 16, 2010
Bought 3.52 K USD
Graeff Scott A
Interim CFO; CCO
+ 1900
1.85 USD
15 years ago
Jan 13, 2010
Bought 39.5 K USD
Dalhouse Warner
Director
+ 10000
3.95 USD
16 years ago
Feb 19, 2008
Sell 4.34 K USD
Ferris Kenneth D
President Advanced System Div
- 600
7.24 USD
17 years ago
Oct 30, 2007
Sell 415 K USD
Meller Scott A
Pres., Technology Development
- 59348
7 USD
17 years ago
Oct 30, 2007
Sell 415 K USD
Meller Scott A
Pres. Technology Development
- 59348
7 USD
17 years ago
May 21, 2007
Sell 57 K USD
Engebritson Lori D
VP Human Resources
- 10958
5.2 USD
17 years ago
May 03, 2007
Sell 23.7 K USD
Meller Scott A
Pres., Technology Development
- 7910
3 USD
17 years ago
May 03, 2007
Sell 1.27 K USD
Hullman Aaron S
Vice Pres. and General Counsel
- 424
3 USD
17 years ago
May 03, 2007
Sell 13.3 K USD
Goehrke John T
- 4435
3 USD
17 years ago
Apr 02, 2007
Sell 673 USD
Hullman Aaron S
Vice Pres. and General Counsel
- 200
3.365 USD
17 years ago
Apr 03, 2007
Sell 2.37 K USD
Hullman Aaron S
Vice Pres. and General Counsel
- 789
3.0094 USD
17 years ago
Apr 02, 2007
Sell 673 USD
Goehrke John T
Chief Operating Officer
- 200
3.365 USD
17 years ago
Apr 03, 2007
Sell 14.4 K USD
Goehrke John T
Chief Operating Officer
- 4800
3.0094 USD
17 years ago
Apr 02, 2007
Sell 673 USD
Meller Scott A
Pres., Technology Development
- 200
3.365 USD
17 years ago
Apr 03, 2007
Sell 24.9 K USD
Meller Scott A
Pres., Technology Development
- 8279
3.0094 USD
17 years ago
Mar 08, 2007
Sell 5.91 K USD
Meller Scott A
Pres., Technology Development
- 1876
3.1488 USD
17 years ago
Mar 09, 2007
Sell 19.9 K USD
Meller Scott A
Pres., Technology Development
- 6603
3.0205 USD
17 years ago
Mar 08, 2007
Sell 3.49 K USD
Goehrke John T
Chief Operating Officer
- 1107
3.1488 USD
17 years ago
Mar 09, 2007
Sell 11.8 K USD
Goehrke John T
Chief Operating Officer
- 3893
3.0205 USD
17 years ago
Mar 08, 2007
Sell 690 USD
Hullman Aaron S
Vice Pres. and General Counsel
- 219
3.1488 USD
17 years ago
Mar 09, 2007
Sell 2.33 K USD
Hullman Aaron S
Vice Pres. and General Counsel
- 770
3.0205 USD
7. News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luna Innovations Incorporated - LUNA NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Luna Innovations Incorporated ("Luna Innovations" or the "Company") (NASDAQ:LUNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accesswire.com - 1 week ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Luna Innovations Incorporated (LUNA) and Encourages Investors to Learn More About the Investigation NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 2 weeks ago
Luna Innovations Incorporated (LUNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 3 weeks ago
Luna Announces Resignation of Pamela Coe ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (Nasdaq: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that, Pamela Coe, a member of the Board of Directors (the “Board”), will be retiring from the Luna board effective today. Ms. Coe was elected to the Board in May 2021 for a three-year term. “We are very grateful for Pam's notable contributions and leadership throughout her time on the Board,” said Barry Phelps, Chairman of the Boa. businesswire.com - 3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Luna Innovations Incorporated (LUNA) and Encourages Stockholders to Learn More About the Investigation NEW YORK CITY, NY / ACCESSWIRE / December 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages Luna Innovations Incorporated (LUNA) Investors to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESSWIRE / December 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 4 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Luna Innovations Incorporated (LUNA) And Encourages Investors to Reach Out NEW YORK CITY, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 1 month ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Luna Innovations Incorporated (LUNA) And Encourages Stockholders to Reach Out NEW YORK CITY, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 1 month ago
LUNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Luna Innovations Incorporated and Encourages Investors to Contact the Firm NEW YORK CITY, NY / ACCESSWIRE / December 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LUNA. accesswire.com - 1 month ago
Luna Innovations Receives Additional Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (Nasdaq: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that it has received a written notice (the “Notice”) on November 14, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the “Q3 2024 Form 10-Q”) and because the Company remains delinque. businesswire.com - 2 months ago
Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements – Investor & analyst webcast, including a key opinion leader panel, to be held Monday, November 18 th at 7:30 a.m. EST globenewswire.com - 2 months ago
LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (NASDAQ: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board of directors of Luna Innovation have breached their fiduciary duties to the company. globenewswire.com - 2 months ago
8. Profile Summary

Luna Innovations Incorporated LUNA

image
COUNTRY US
INDUSTRY Hardware, Equipment & Parts
MARKET CAP $ 37.1 M
Dividend Yield 0.00%
Description Luna Innovations Incorporated develops, manufactures, and markets fiber optic test, measurement, and control products worldwide. The company offers optical test and measurement products, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and Hyperion sensing solution that enables full-spectrum data acquisition and flexible peak detect algorithms of fiber-bragg gratings (FBGs), long period FBGs, and fabry-perot sensors with low-latency access to data for closed loop feedback applications. It also provides polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; single frequency lasers; temperature and strain sensing products; ODiSI sensing solution, which provides distributed strain and temperature measurements; and Terametrix terahertz gauging and imaging products that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements, as well as distributed acoustic sensing intellectual property and products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.
Contact 301 1st Street, SW, Roanoke, VA, 24011 https://www.lunainc.com
IPO Date June 5, 2006
Employees 337
Officers Mr. William L. Phelan Chief Financial Officer & Chief Accounting Officer Dr. Kevin Ilcisin President, Chief Executive Officer & Director Ms. Allison L. Woody Senior Director of Administration Mr. Ryan H. Stewart Senior Vice President, General Counsel & Corporate Secretary Ms. Eva Hartmann Senior Vice President of Human Resources Mr. Thomas Oldemeyer Senior Vice President & MD of EMEA Mr. Will Denman Senior Vice President of Sales - North America